Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Filings indexed 238 across all filing types
Latest filing 2023-05-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Amendment to Securities Registration Statement) filed by QURATIS. It details changes to the public offering schedule, subscription dates, and financial information updates. In the context of financial filings, a Securities Registration Statement (and its amendments) is a primary regulatory document for capital raising, which falls under the 'Regulatory Filings' category as it is a formal submission to the financial regulator (DART/FSS) that does not fit into more specific categories like 'Earnings Release' or 'Annual Report'.
2023-05-04 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) amendment (정정신고서) filed by Quratis Inc. It details changes to the public offering schedule, subscription dates, and related procedural information for a stock issuance. This type of regulatory filing is a formal document submitted to the financial authority (FSS/DART) to update previously filed registration materials. According to the provided definitions, this falls under 'Regulatory Filings' (RNS) as it is a formal regulatory announcement regarding the amendment of a securities registration statement.
2023-04-24 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed by Quratis Inc. with the Financial Services Commission (FSC) in South Korea. It details the company's intent to offer shares (3,500,000 shares) to the public, including investment risks, business overview, and financial information. This is a formal regulatory filing required for an IPO or public offering of securities. In the context of the provided categories, this fits the definition of a regulatory filing for capital raising.
2023-04-03 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 7th fiscal year (2022), which is the standard Korean terminology for an Annual Report (10-K equivalent). It contains comprehensive company information, including history, management, capital structure, and business operations, consistent with the requirements for an annual filing submitted to the Financial Services Commission and the Korea Exchange. FY 2022
2023-03-31 Korean
[기재정정]분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) from Curatis Inc. (주식회사 큐라티스), which has been amended (정정신고). It contains detailed financial statements, including the Statement of Financial Position, Statement of Comprehensive Income, and Statement of Changes in Equity, along with comparative data for previous periods. Since it provides comprehensive financial data for a period shorter than a full fiscal year (3rd quarter), it is classified as an Interim/Quarterly Report (IR). 9M 2022
2023-02-03 Korean
[첨부추가]분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 3rd quarter of the 7th fiscal year (2022) for Quratis Inc. It contains detailed company information, history, capital changes, and business descriptions, which are characteristic of a comprehensive interim financial report. It is not an announcement or a summary, but the full report itself. 9M 2022
2022-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.